Home›Companies›Healthcare›Spirair

Spirair, Inc.

Makes nasal treatment devices for physicians treating patients.

Updated Nov 11, 2026·Latest SEC filing Mar 10, 2026·Suggest an edit

About Spirair

Spirair is a private company based in South San Francisco, California. It has reported $24,722,385 raised in one offering on Form D since August 2025. Its chief executive is Ben Bishop.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 28, 2025Aug 12, 2025amended Mar 10, 2026$24,722,385of $28.2M target55$449KEquityRule 506(b)Form D/A ↗1 earlier filing

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Spirair's Form D filed Mar 10, 2026.

RB
Rob Binney
Director
Also a director at Eyenuk and CEO and director at ShiraTronics.
James Kintzing
James Kintzing
Co-Founder and CTO, director
CM
Carter Meyer
Director
Kate Garrett
Kate Garrett
Director
Also a director at BRIUS.
Ben Bishop
Ben Bishop
CEO and director

Sources

  1. SECSpirair, Inc. Form D, filed Aug 12, 2025
  2. SECSpirair, Inc. filing history
  3. CompanyAbout Spirair
  4. ResearchFDA device document